Adjuvant system for vaccine adjuvant
AssigneeVaxform LLC
InventorGarry Morefield
Life of this patent
Estimating the term…
Abstract
The present invention provides adjuvant compositions that have improved stability, increased potency and which provide an enhanced Th1 response. The present invention also provides methods of making those compositions and administration of the improved adjuvant compositions
Claims31
An immunological composition comprising one or more C-type lectin(CTL) receptor ligands and one or more aluminum adjuvants and one or more antigens.
A method of stimulating an immune response in a mammal comprising administering to the mammal an immunological composition comprising one or more C-type lectin (CTL) receptor ligands and one or more aluminum adjuvants and one or more antigens.
An adjuvant comprising one or more C-type lectin (CTL) receptor ligands and one or more aluminum adjuvants and one or more antigens.
A method of making a vaccine adjuvant comprising combining a one or more C-type lectin (CTL) receptor ligands and one or more aluminum adjuvants.
Dependencies are inferred from the claim text.